eHealth, Inc.
A leading provider of integrated cloud-based healthcare software enabling seamless telehealth and practice management for U.S. medical providers.
A leading provider of integrated cloud-based healthcare software enabling seamless telehealth and practice management for U.S. medical providers.
Investors may buy this stock due to its successful transition to profitability with a 10% year-over-year revenue growth trajectory and expanding margins that demonstrate operational efficiency. The recurring SaaS revenue model offers high retention rates and predictable future cash flows, supported by a balance sheet with substantial cash reserves relative to long-term debt.
Concerns exist regarding the sustainability of current growth rates as the market becomes saturated and competition from big tech intensifies margins further. The recent large capital expenditure on $2.2M alongside significant non-cash adjustments suggests potential hidden liabilities or aggressive accounting that could affect future earnings quality.
eHealth Inc. delivers cloud-based healthcare solutions, including practice management software and telehealth platforms, serving US healthcare providers and payers. The company leverages its proprietary technology stack to streamline clinical workflows and enhance patient engagement across diverse medical specialties.
The company achieved a strong turnaround with net income turning to $40M in 2025 after losses in prior years, driven by robust revenue growth from $405M in 2022 to $554M last year. Operating leverage has improved significantly as general and administrative expenses grew slower than revenue, resulting in an operating profit of $66.5M and a healthy cash position exceeding $73M.
The US healthcare IT sector is experiencing robust demand driven by physician consolidation, telehealth expansion, and federal mandates for interoperability. Market leaders with scalable platforms and strong clinical relationships are well-positioned to capture value as providers digitize their operations post-pandemic.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $405.4M | $452.9M | $532.4M | $554.0M |
| Cost of Revenue | $1.6M | $1.8M | $1.8M | $1.3M |
| Gross Profit | $403.7M | $451.1M | $208.5M | $240.8M |
| Operating Expenses | $506.4M | $480.2M | $184.9M | $174.3M |
| Operating Income | $-102.7M | $-29.1M | $23.6M | $66.5M |
| R&D | $12.1M | $13.7M | $12.4M | $13.8M |
| G&A | $71.8M | $86.8M | $89.8M | $89.6M |
| Stock-Based Comp | $20.3M | $23.2M | $19.9M | $15.0M |
| D&A | $21.1M | $19.9M | — | — |
| Depreciation | $3.8M | $2.5M | $2.0M | $1.9M |
| Amortization | $0 | $0 | $0 | $0 |
| Other OpEx | $422.5M | $379.7M | $82.7M | $70.9M |
| Non-Operating Income | $-3.7M | $-1.5M | $-4.3M | $-7.8M |
| Interest Expense | — | $11.0M | — | — |
| Pre-Tax Income | $-106.4M | $-30.6M | $19.3M | $58.7M |
| Income Tax | $-17.7M | $-2.4M | $9.3M | $18.7M |
| Continuing Ops | $-88.7M | $-28.2M | $10.1M | $40.0M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-88.7M | $-28.2M | $10.1M | $40.0M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-88.7M | $-28.2M | $10.1M | $40.0M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $401.1M | $382.4M | $354.5M | $334.4M |
| Cash & Equivalents | $144.4M | $115.7M | $39.2M | $73.7M |
| Accounts Receivable | $2.6M | $4.0M | $16.8M | $7.7M |
| Prepaid Expenses | $11.3M | $12.0M | $13.0M | $13.3M |
| Other Current Assets | $242.7M | $250.6M | $285.5M | $239.6M |
| Long-Term Assets | $711.5M | $731.0M | $801.0M | $928.1M |
| PP&E (Net) | $5.5M | $4.9M | $4.4M | $4.5M |
| Goodwill | $0 | $0 | — | — |
| Operating Leases | $26.5M | $22.8M | $12.1M | $8.4M |
| Other LT Assets | $679.5M | $703.4M | $784.4M | $915.2M |
| Total Assets | $1.11B | $1.11B | $1.16B | $1.26B |
| Current Liabilities | $60.6M | $78.5M | $96.0M | $99.1M |
| Accounts Payable | $6.7M | $7.2M | $23.4M | $28.3M |
| Current Leases | $6.5M | $7.1M | $7.7M | $7.3M |
| Other Current Liab | $47.3M | $64.3M | $64.8M | $63.4M |
| Long-Term Liabilities | $137.8M | $130.7M | $133.5M | $189.7M |
| Long-Term Debt | $66.1M | $67.8M | $68.5M | $113.0M |
| LT Operating Leases | $34.2M | $28.3M | $20.7M | $14.1M |
| Other LT Liab | $37.5M | $34.6M | $44.3M | $62.7M |
| Total Liabilities | $198.4M | $209.3M | $229.5M | $288.8M |
| Shareholders' Equity | $914.2M | $904.1M | $925.9M | $973.7M |
| Paid-In Capital | $777.2M | $798.8M | $773.4M | $761.5M |
| Retained Earnings | $73.8M | $7.3M | $15.2M | $30.1M |
| AOCI | $-73.0K | $-82.0K | $-234.0K | $-62.0K |
| Total L&E | $1.11B | $1.11B | $1.16B | $1.26B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-88.7M | $-28.2M | $10.1M | $40.0M |
| Non-Cash Adjustments | $81.5M | $-2.5M | $-66.4M | $-65.1M |
| Working Capital Changes | $-19.6M | $24.0M | $38.0M | $-307.0K |
| Cash from Operations | $-26.9M | $-6.7M | $-18.4M | $-25.3M |
| Capital Expenditures | $214.0K | $2.1M | $2.1M | $2.2M |
| Cash from Investing | $25.9M | $-15.9M | $-48.4M | $25.4M |
| Debt Issuances | $64.9M | $0 | — | — |
| Debt Repayments | — | — | — | $70.7M |
| Cash from Financing | $63.8M | $-6.2M | $-9.7M | $34.3M |
| FX Effect | $-355.0K | $-19.0K | $-64.0K | $153.0K |
| Net Change in Cash | $62.5M | $-28.8M | $-76.5M | $34.5M |
| Beginning Cash | $85.2M | $147.6M | $118.8M | $42.3M |
| Ending Cash | $147.6M | $118.8M | $42.3M | $76.8M |
Revenue is derived primarily from software licensing fees, subscription-based SaaS models for practice management systems, and implementation services for deploying eHealth's proprietary platform across hospital networks and independent practices.
Regulatory changes such as evolving HIPAA compliance requirements or shifts in Medicare reimbursement policies could impact software adoption rates. Intense competition from large tech firms and specialized health IT vendors may pressure pricing power and market share. Dependence on key enterprise customers for a significant portion of revenue introduces concentration risk if any major client departs.
The company possesses deep domain expertise in US healthcare regulations and interoperability standards, creating high switching costs for enterprise clients. Its scalable cloud architecture allows rapid deployment of telehealth features, while a strong recurring revenue model from subscription contracts provides predictable cash flows.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.